Trials / Unknown
UnknownNCT04902079
Observational and Prospective Registry on Cardiac Contractility Modulation (CCM) Therapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Monaldi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Observational and perspective study with acute and chronic endpoint.
Detailed description
This registry includes patients who have undergone implantation of the cardiac contractility modulation device due to the presence of heart failure with reduced left ventricular systolic function and symptomatic despite optimal therapy, as indicated in the guidelines of the ESC of 2016 and the Expert Consensus Document of the ESC Heart Failure group published in May 2019 for to assess the benefits after the CCM device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device for Cardiac Contractility Modulation Therapy (CCM) | Evaluate the effect from CCM Therapy in HF population |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2022-06-30
- Completion
- 2023-12-31
- First posted
- 2021-05-26
- Last updated
- 2021-06-03
Locations
1 site across 1 country: Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04902079. Inclusion in this directory is not an endorsement.